Kadmus Pharmaceuticals, Inc.
Kadmus
Pharmaceuticals is actively seeking partnership(s) for the KDS-5000
program, the series of OEA-based pharmaceutical and nutraceutical
products. Administration of OEA can result in weight reduction,
lower food intake and improvement of various lipid profiles (i.e. in
blood and in liver). For more information, please contact us at
the address below.
Kadmus Pharmaceuticals, Inc.
partnering@kadmuspharma.com
Thank you for your interest.